[Aspects of dental care of immunosuppressed patients. I].
Folwaczny
M
M
Poliklinik für Zahnerhaltung und Parodontologie Ludwig-Maximilians-Universität München Goethestrasse 70 D-80336 München. mfolwa@dent.med.uni-muenchen.de
Hickel
R
R
D000293:Adolescent; D000328:Adult; D000891:Anti-Infective Agents, Local / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects; D016026:Bone Marrow Transplantation / Q000009:adverse effects; D002648:Child; D002710:Chlorhexidine / Q000627:therapeutic use; D003729:Dental Care; D004708:Endodontics; D006084:Graft Rejection; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects; D006801:Humans; D016867:Immunocompromised Host / Q000276:immunology; D007938:Leukemia / Q000150:complications / Q000188:drug therapy; D008223:Lymphoma / Q000150:complications / Q000188:drug therapy; D009061:Mouth Mucosa / Q000187:drug effects; D009067:Mouthwashes; D009369:Neoplasms / Q000150:complications / Q000188:drug therapy; D006472:Oral Hemorrhage / Q000139:chemically induced; D009910:Oral Hygiene; D019647:Oral Surgical Procedures; D010377:Pediatric Dentistry; D010517:Periodontics; D012307:Risk Factors; D012469:Salivary Glands / Q000187:drug effects
D000891:Anti-Infective Agents, Local; D000970:Antineoplastic Agents; D009067:Mouthwashes; D002710:Chlorhexidine